Literature DB >> 28709721

Screening for TMEM230 mutations in young-onset Parkinson's disease.

Dongrui Ma1, Jia Nee Foo2, Ebonne Yulin Ng1, Yi Zhao3, Jian-Jun Liu4, Eng King Tan5.   

Abstract

TMEM230 gene mutations have been reported to be linked with Parkinson's disease (PD) recently. To investigate the prevalence of this gene in southeastern Chinese patients with PD, whole exome sequencing was performed in young-onset and familial PD patients and healthy controls in our Asian population. One heterozygous missense p.Phe121Ser mutation was detected in a healthy 76-year-old control subject and no other TMEM230 mutations were found in PD patients and controls. These data suggest that TMEM230 mutation might be a rare cause of Chinese familial and sporadic PD patients and a larger sample size will be needed to evaluate the association of TMEM230 polymorphic variants with PD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mutation screening; Parkinson's disease; TMEM230; Whole exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28709721     DOI: 10.1016/j.neurobiolaging.2017.06.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

Review 1.  Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.

Authors:  Sara Bandres-Ciga; Monica Diez-Fairen; Jonggeol Jeff Kim; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2020-01-25       Impact factor: 5.996

Review 2.  The Role of TMEM230 Gene in Parkinson's Disease.

Authors:  Hao Deng; Kuan Fan; Joseph Jankovic
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

3.  TMEM230 in Parkinson's disease in a southern Spanish population.

Authors:  Cristina Tejera-Parrado; Silvia Jesús; Adrián López-Ruíz; Dolores Buiza-Rueda; Marta Bonilla-Toribio; Inmaculada Bernal-Bernal; María Teresa Periñán; Laura Vargas-González; Pilar Gómez-Garre; Pablo Mir
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.